IPOS - Blue Water Vaccines stock sinks 26% in wake of quarterly earnings report
Blue Water Vaccines (BWV) shares sank 26% in afternoon trading Monday in the wake of the company’s Q1 earnings report. Shares of the vaccine developer opened at $5.24. The stock recently changed hands at $4.22, down 26%, at approximately 3:35 p.m. ET. BWV released its Q1 earnings report after market close on Friday, reporting a widened quarterly loss. Shares of the biotech company have been highly volatile since its $20M initial public offering on Feb. 18, which saw its stock soar nearly 540%. BWV had priced 2.2M shares at $9 per share. For more IPO news, check out SA’s IPO News page.
For further details see:
Blue Water Vaccines stock sinks 26% in wake of quarterly earnings report